文献速递复苏、休克与脓毒症儿科与产科急症

抑制二甲基精氨酸二甲基氨基水解酶1改善妊娠小鼠脓毒症结局

Inhibition of Dimethylarginine Dimethylaminohydrolase 1 Improves the Outcome of Sepsis in Pregnant Mice.
PubMed 文献 · Shock · 2020-01-01
一句话结论在妊娠小鼠CLP脓毒症模型中,亚胺培南联合DDAH1选择性抑制剂L-257使生存率从13%(NaCl)提高至50%,并防止心血管崩溃、改善器官功能与杀菌能力。

脓毒症是孕产妇死亡的重要原因之一。作者在妊娠小鼠盲肠结扎穿刺(CLP)模型中,于CLP后3小时给予亚胺培南和/或DDAH1选择性抑制剂L-257,3小时后取样。单用亚胺培南生存率从13%(NaCl)升至20%,单用L-257升至33%,两者联用显著提高至50%。联用防止心血管崩溃、改善器官功能和细菌清除,但未减少肺部炎症细胞数,反而增加肺细胞因子水平。作者认为常规管理联合DDAH1选择性抑制可能对妊娠期脓毒症有治疗潜力。

要点

  • 妊娠小鼠CLP脓毒症模型中,NaCl组生存率13%,亚胺培南单药20%,L-257单药33%,两药联用50%。
  • 亚胺培南与L-257联用可防止心血管崩溃,并改善器官功能与细菌清除。
  • 联用未减少肺部炎症细胞数,反而增加肺细胞因子水平。
  • 治疗于CLP后3小时给予,3小时后取样。
  • 作者认为常规管理联合DDAH1选择性抑制可能对妊娠期脓毒症有治疗潜力。

适用人群与场景

  • 妊娠小鼠盲肠结扎穿刺(CLP)多微生物脓毒症模型;CLP后3小时给药,给药3小时后取样。

处置流程与药物剂量

  • CLP后3小时给予亚胺培南(Imipenem)和/或DDAH1选择性抑制剂L-257;给药剂量原文未写明。
  • 亚胺培南单药使生存率从13%(NaCl)升至20%;L-257单药升至33%;两药联用升至50%。

研究设计与关键结果

  • 研究类型为动物实验(妊娠小鼠CLP脓毒症模型),比较NaCl、亚胺培南单药、L-257单药及两药联用的生存率:NaCl组13%,亚胺培南组20%,L-257组33%,联用组50%。
  • 联用防止心血管崩溃,改善器官功能与细菌清除;未减少肺部炎症细胞数,反而增加肺细胞因子水平。

证据类型、等级与局限

  • 证据类型:动物实验(妊娠小鼠CLP脓毒症模型)。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为常规管理联合DDAH1选择性抑制可能对妊娠期脓毒症有治疗潜力。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

Sepsis is one of the most important causes of maternal mortality. In our previous work, we established a polymicrobial sepsis (cecal ligation and puncture [CLP]) model in murine pregnancy and found that pregnant mice had a greater susceptibility to septic shock. In this model, mortality seemed to be associated with the development of early hemodynamic dysfunction and although circulating cytokine levels were similar, "off target" lung inflammatory cell numbers were greater in pregnant mice.Here, we have used the same CLP model to test the hypothesis that inhibiting the metabolism of the endogenous inhibitor of nitric oxide synthase, asymmetric dimethylarginine would improve the outcome of sepsis in pregnancy. We used a dimethylarginine dimethylaminohydrolase 1-selective inhibitor (L-257), which reduces vascular nitric oxide synthesis without impairing immune cell function, in combination with a broad-spectrum antibiotic (Imipenem) and studied the outcome of septic shock in pregnant mice. Treatments were administered 3 h after CLP and samples were taken 3 h later. Both Imipenem and L-257 treatment alone slightly improved mortality rates from 13% (NaCl) to 20% (Imipenem) and 33% (L-257), whereas the combination of Imipenem and L-257 significantly improved survival to 50%. Imipenem and L-257 together prevented cardiovascular collapse and improved both organ function and bacterial killing, but did not reduce lung inflammatory cell numbers and actually increased lung cytokine levels.These data suggest that conventional management in combination with selective inhibition of DDAH1 may have therapeutic potential in the management of sepsis in pregnancy.

来源:Shock,查看原文。版权归原作者所有。

参考来源

  1. Zölner J, Lambden S, Nasri NM, et al. Inhibition of Dimethylarginine Dimethylaminohydrolase 1 Improves the Outcome of Sepsis in Pregnant Mice. Shock. 2020. PMID: 31821207. doi:10.1097/SHK.0000000000001490

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。